CNS & Neurological Disorders - Drug Targets

(Formerly Current Drug Targets - CNS & Neurological Disorders)

Editor-in-Chief:

Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL
USA

Back

Alzheimers Disease, Ceramide, Visfatin and NAD

Volume:7   Issue:6
Pp: 492-498
James D. Adams Jr.
DOI: 10.2174/187152708787122969

Alzheimers Disease Drug Development: Old Problems Require New Priorities

Volume:7   Issue:6
Pp: 499-511
Robert E. Becker and Nigel H. Greig
DOI: 10.2174/187152708787122950

The proNGF-p75NTR-Sortilin Signalling Complex as New Target for the Therapeutic Treatment of Parkinsons Disease

Volume:7   Issue:6
Pp: 512-523
L. W. Chen, K. K.L. Yung, Y. S. Chan, D. K.Y. Shum and J. P. Bolam
DOI: 10.2174/187152708787122923

Central Sensitisation Phenomena in Primary Headaches: Overview of a Preventive Therapeutic Approach

Volume:7   Issue:6
Pp: 524-535
M. de Tommaso, M. Sardaro, E. Vecchio, C. Serpino, M. Stasi and M. Ranieri
DOI: 10.2174/187152708787122932

NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis open access plus

Volume:7   Issue:6
Pp: 536-557
J. Yan and J. M. Greer
DOI: 10.2174/187152708787122941